Table of Contents

1 Product Introduction and Overview

• 1.1 Product Definition
• 1.2 Product Specification
• 1.3 Global Market Overview
  • 1.3.1 Global Valacyclovir Market Status and Forecast (2016-2027)
  • 1.3.2 Global Valacyclovir Sales Value CAGR by Region
• 1.4 Market Drivers, Inhibitors
  • 1.4.1 Market Drivers
  • 1.4.2 Market Inhibitors
  • 1.4.3 COVID-19 Impact Analysis

2 Global Valacyclovir Supply by Company

• 2.1 Global Valacyclovir Sales Volume by Company
• 2.2 Global Valacyclovir Sales Value by Company
• 2.3 Global Valacyclovir Price by Company
• 2.4 Valacyclovir Production Location and Sales Area of Main Manufacturers
• 2.5 Trend of Concentration Rate

3 Global and Regional Valacyclovir Market Status by Type

• 3.1 Valacyclovir Type Introduction
  • 3.1.1 Tablets
  • 3.1.2 Capsule
  • 3.1.3 Granules
• 3.2 Global Valacyclovir Market by Type
  • 3.2.1 Global Valacyclovir Sales Volume by Type (2016-2021)
  • 3.2.2 Global Valacyclovir Sales Value by Type (2016-2021)
  • 3.2.3 Global Valacyclovir Price by Type (2016-2021)
• 3.3 North America: by Type
• 3.4 Europe: by Type
• 3.5 Asia Pacific: by Type
• 3.6 Central & South America: by Type
• 3.7 Middle East & Africa: by Type

4 Global and Regional Valacyclovir Market Status by Application

• 4.1 Valacyclovir Segment by Application
  • 4.1.1 Herpes Zoster Virus
  • 4.1.2 Herpes Simplex Virus
  • 4.1.3 EB Virus
  • 4.1.4 Cytomegalovirus
• 4.2 Global Valacyclovir Market by Application
  • 4.2.1 Global Valacyclovir Sales Volume by Application (2016-2021)
  • 4.2.2 Global Valacyclovir Sales Value by Application (2016-2021)
  • 4.2.3 Global Valacyclovir Price by Application (2016-2021)
• 4.3 North America: by Application
• 4.4 Europe: by Application
• 4.5 Asia Pacific: by Application
• 4.6 Central & South America: by Application
• 4.7 Middle East & Africa: by Application

5 Global Valacyclovir Market Status by Region

• 5.1 Global Valacyclovir Market by Region
  • 5.1.1 Global Valacyclovir Sales Volume by Region
  • 5.1.2 Global Valacyclovir Sales Value by Region
• 5.2 North America Valacyclovir Market Status
• 5.3 Europe Valacyclovir Market Status
• 5.4 Asia Pacific Valacyclovir Market Status
• 5.5 Central & South America Valacyclovir Market Status
• 5.6 Middle East & Africa Valacyclovir Market Status

6 North America Valacyclovir Market Status

• 6.1 North America Valacyclovir Market by Country
  • 6.1.1 North America Valacyclovir Sales Volume by Country (2016-2021)
  • 6.1.2 North America Valacyclovir Sales Value by Country (2016-2021)
• 6.2 United States
• 6.3 Canada
• 6.4 Mexico

7 Europe Valacyclovir Market Status

• 7.1 Europe Valacyclovir Market by Country
  • 7.1.1 Europe Valacyclovir Sales Volume by Country (2016-2021)
  • 7.1.2 Europe Valacyclovir Sales Value by Country (2016-2021)
• 7.2 Germany
• 7.3 France
• 7.4 UK
• 7.5 Italy
• 7.6 Russia
• 7.7 Spain

8 Asia Pacific Valacyclovir Market Status

• 8.1 Asia Pacific Valacyclovir Market by Country
  • 8.1.1 Asia Pacific Valacyclovir Sales Volume by Country (2016-2021)
  • 8.1.2 Asia Pacific Valacyclovir Sales Value by Country (2016-2021)
• 8.2 China
• 8.3 Japan
• 8.4 Korea
• 8.5 Southeast Asia
• 8.6 India
• 8.7 Australasia

9 Central & South America Valacyclovir Market Status

• 9.1 Central & South America Valacyclovir Market by Country
  • 9.1.1 Central & South America Valacyclovir Sales Volume by Country (2016-2021)
  • 9.1.2 Central & South America Valacyclovir Sales Value by Country (2016-2021)
• 9.2 Brazil
• 9.3 Argentina
• 9.4 Colombia

10 Middle East & Africa Valacyclovir Market Status

• 10.1 Middle East & Africa Valacyclovir Market by Country
  • 10.1.1 Middle East & Africa Valacyclovir Sales Volume by Country (2016-2021)
  • 10.1.2 Middle East & Africa Valacyclovir Sales Value by Country (2016-2021)
• 10.2 Iran
• 10.3 Israel
• 10.4 Turkey
• 10.5 South Africa
• 10.8 Saudi Arabia

11 Supply Chain and Manufacturing Cost Analysis

• 11.1 Supply Chain Analysis
• 11.2 Production Process Chart Analysis
• 11.3 Raw Materials and Key Suppliers Analysis
  • 11.3.1 Raw Materials Introduction
  • 11.3.2 Raw Materials Key Suppliers List
• 11.4 Valacyclovir Manufacturing Cost Analysis
• 11.5 Valacyclovir Sales Channel and Distributors Analysis
  • 11.5.1 Valacyclovir Sales Channel
  • 11.5.2 Valacyclovir Distributors
• 11.6 Valacyclovir Downstream Major Buyers

12 Global Valacyclovir Market Forecast by Type and by Application

• 12.1 Global Valacyclovir Sales Volume and Sales Value Forecast (2022-2027)
• 12.2 Global Valacyclovir Forecast by Type
  • 12.2.1 Global Valacyclovir Sales Volume Forecast by Type
  • 12.2.2 Global Valacyclovir Sales Value Forecast by Type
  • 12.2.3 Global Valacyclovir Price Forecast by Type
• 12.3 Global Valacyclovir Forecast by Application
  • 12.3.1 Global Valacyclovir Sales Volume Forecast by Application
  • 12.3.2 Global Valacyclovir Sales Value Forecast by Application
  • 12.3.3 Global Valacyclovir Price Forecast by Application

13 Global Valacyclovir Market Forecast by Region/Country

• 13.1 Global Valacyclovir Market Forecast by Region (2022-2027)
  • 13.1.1 Global Valacyclovir Sales Volume Forecast by Region (2022-2027)
  • 13.1.2 Global Valacyclovir Sales Value Forecast by Region (2022-2027)
• 13.2 North America Market Forecast
• 13.3 Europe Market Forecast
• 13.4 Asia Pacific Market Forecast
• 13.5 Central & South America Market Forecast
• 13.6 Middle East & Africa Market Forecast

14 Key Participants Company Information

• 14.1 GSK
  • 14.1.1 Company Information
  • 14.1.2 Valacyclovir Product Introduction
  • 14.1.3 GSK Valacyclovir Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.1.4 SWOT Analysis
• 14.2 Zhuhai Rundu Pharmaceutical
  • 14.2.1 Company Information
  • 14.2.2 Valacyclovir Product Introduction
  • 14.2.3 Zhuhai Rundu Pharmaceutical Valacyclovir Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.2.4 SWOT Analysis
• 14.3 Yongxin Pharmaceutical Industry
  • 14.3.1 Company Information
  • 14.3.2 Valacyclovir Product Introduction
  • 14.3.3 Yongxin Pharmaceutical Industry Valacyclovir Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.3.4 SWOT Analysis
• 14.4 Yichang Dongyangguang Changjiang Pharmaceutical
  • 14.4.1 Company Information
  • 14.4.2 Valacyclovir Product Introduction
  • 14.4.3 Yichang Dongyangguang Changjiang Pharmaceutical Valacyclovir Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.4.4 SWOT Analysis
• 14.5 Sorres Pharma
  • 14.5.1 Company Information
  • 14.5.2 Valacyclovir Product Introduction
  • 14.5.3 Sorres Pharma Valacyclovir Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.5.4 SWOT Analysis
• 14.6 Sivem Pharmaceuticals
  • 14.6.1 Company Information
  • 14.6.2 Valacyclovir Product Introduction
  • 14.6.3 Sivem Pharmaceuticals Valacyclovir Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.6.4 SWOT Analysis
• 14.7 Sichuan Mingxin Pharmaceutical
  • 14.7.1 Company Information
  • 14.7.2 Valacyclovir Product Introduction
  • 14.7.3 Sichuan Mingxin Pharmaceutical Valacyclovir Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.7.4 SWOT Analysis
• 14.8 Sichuan Kelun Pharmaceutical
  • 14.8.1 Company Information
  • 14.8.2 Valacyclovir Product Introduction
  • 14.8.3 Sichuan Kelun Pharmaceutical Valacyclovir Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.8.4 SWOT Analysis
• 14.9 Sichuan Baili Pharmaceutical
  • 14.9.1 Company Information
  • 14.9.2 Valacyclovir Product Introduction
  • 14.9.3 Sichuan Baili Pharmaceutical Valacyclovir Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.9.4 SWOT Analysis
• 14.10 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
  • 14.10.1 Company Information
  • 14.10.2 Valacyclovir Product Introduction
  • 14.10.3 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Valacyclovir Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.10.4 SWOT Analysis
• 14.11 Shandong New Era Pharmaceutical
• 14.12 Shandong Luoxin Pharmaceutical Group
• 14.13 Remedy Repack
• 14.14 PLIVA
• 14.15 Mylan Pharmaceuticals
• 14.16 Marcan Pharmaceuticals
• 14.17 Livzon Pharmaceutical Group
• 14.18 Kunming Yuanrui Pharmaceutical
• 14.19 Jamp Pharma Corporatio
• 14.20 Hubei Yikang Pharmaceutical Factory
• 14.21 Hubei Keyi Pharmaceutical
• 14.22 Hubei Huashitong Qianlong Pharmaceutical
• 14.23 Guangdong Baike Pharmaceutical
• 14.24 Cobalt Laboratories (Allergan)
• 14.25 Chengdu Beite Pharmaceutical
• 14.26 Biomed Pharma
• 14.27 Beijing Shuanglu Pharmaceutical
• 14.28 Auro Pharma
• 14.29 Apotex Corporation
• 14.30 Ansi Pharmaceutical

15 Conclusion

16 Methodology

This report provides a comprehensive analysis of current global Valacyclovir market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Valacyclovir industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

According to this survey, the global Valacyclovir market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million by 2027.

Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Valacyclovir Market Status and Forecast 2021-2027 report makes a brilliant attempt to unveil key opportunities available in the global Valacyclovir market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

The Global Valacyclovir Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Valacyclovir industry.
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions

Segmented by Type
Tablets
Capsule

Segmented by Application
Herpes Zoster Virus
Herpes Simplex Virus
EB Virus
Cytomegalovirus

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Yongxin Pharmaceutical Industry
Yichang Dongyangguang Changjiang Pharmaceutical
Sorres Pharma
Sivem Pharmaceuticals
Sichuan Mingxin Pharmaceutical
Sichuan Kelun Pharmaceutical
Sichuan Baili Pharmaceutical
Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
Shandong New Era Pharmaceutical
Shandong Luoxin Pharmaceutical Group
Remedy Repack
PLIVA
Mylan Pharmaceuticals
Marcan Pharmaceuticals
Livzon Pharmaceutical Group
Kunming Yuanrui Pharmaceutical
Jamp Pharma Corporatio
Hubei Yikang Pharmaceutical Factory
Hubei Keyi Pharmaceutical
Hubei Huashitong Qianlong Pharmaceutical
Guangdong Baike Pharmaceutical
Cobalt Laboratories (Allergan)
Chengdu Beite Pharmaceutical
Biomed Pharma
Beijing Shuanglu Pharmaceutical
Auro Pharma
Apotex Corporation
Ansi Pharmaceutical